Stock screener

IMA

Conviction 21HealthcareScan · Mon, Aug 10, 2026
IMA$5.64-0.97%
ResistanceSupportVol 14Insider buy
63 bars
Vol MA14 15.51K
May 11May 28Jun 16Jul 6Jul 23Aug 10
ImageneBio, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.imagenebio.com ↗
Price5.64
Change-0.97%
Gap-3.16%
Rel volume5.27×
Avg volume15.13K
Avg $ vol85.12K
SMA 205.71
SMA 505.76
SMA 2006.31
Price vs 50-2.13%
Price vs 200-10.69%
MA stackbearish
50/200 cross—
Supertrendup · 5.11
RSI (14)47
MACD hist-0.00
MACD cross—
Stoch %K / %D47 / 49
ADX (14)10
+DI / −DI17 / 20
RSI divergenceBullish
MACD divergenceBullish
ATR %+5.55%
ADR %4.80%
52w high14.79
52w low4.55
From 52w high-61.90%
Above 52w low+23.85%
New 52w highNo
SqueezeOn · 28d
Bollinger width12.83%
%B0.40
Donchian pos34.62%
Donchian high6.23
Donchian low5.32
AVWAP (52w high)6.39
vs AVWAP high-11.79%
AVWAP (52w low)5.91
vs AVWAP low-4.71%
OBV trendDown
Chaikin MF (20)0.04
Today vs 20d5.27×
Avg vol (14d)15.51K
Avg vol (20d)15.13K
Avg $ vol (20d)85.12K
Market cap63.97M
RS 3m (vs SPY)-9.42%
RS 6m (vs SPY)-32.94%
RS line new highNo
Trend template0/8
Technical rank18.5
1 week-0.09%
1 month-4.65%
3 months+6.52%
6 months-18.45%
1 year-61.67%
YTD-16.64%
P/E-1.41
P/B0.45
P/S79.96
P/FCF-1.33
EPS-9.64
Div yield—
ROE-31.92%
ROA-29.83%
Debt/Eq0.00
Current21.47
EV/EBITDA0.64
Gross margin—
Net margin—
Rev growth-77.14%
EPS growth-24.01%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value-30.71M
Revenue800K
Net income-10.18M
Gross profit—
Free cash flow-48.26M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out11.28M
Employees17
ListedMon, Jul 28, 2025
Free float8.51M
Float %79.8%
Short interest393.69K
Days to cover59.1d
Short volume52.8%
Squeeze score58 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction21 / 100
Pattern quality—
Tech rank18.5 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance6.22
Support5.32
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 46 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

  1. Retesting breakout
    Jun 18
    1 scan
  2. Setting up
    Jun 26 – Aug 4
    12 scans

Congress activity

Disclosed STOCK Act trades in IMA

All disclosures →
No recent disclosed trades by Congress in IMA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in IMA · 7 buys · 2 sells

InsiderSideShares
Yarema Kristin
Chief Executive Officer · Common Stock · 2026-07-25
Exercise38.38K
Yarema Kristin
Chief Executive Officer · Common Stock · 2026-07-25
Acquire115.13K
Yarema Kristin
Chief Executive Officer · Restricted Stock Units · 2026-07-25
Exercise38.38K
Yarema Kristin
Chief Executive Officer · Restricted Stock Units · 2026-07-25
Dispose115.13K
Bonita David P
Director · Stock Option (right to buy) · 2026-06-16
Grant15.6K
SLATTERY JOSEPH P
Director · Stock Option (right to buy) · 2026-06-16
Grant15.6K
Stampacchia Otello
Director · Stock Option (right to buy) · 2026-06-16
Grant15.6K
Wang Jonathan Jian
Director · Stock Option (right to buy) · 2026-06-16
Grant15.6K
Bonita David P
Director · Pre-Funded Warrants (right to buy) · 2026-04-14
Buy384.69K
OrbiMed Capital GP VI LLC
Director · Common Stock · 2026-04-14
Other—

SEC filings

EDGAR filings in IMA · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.